ENDOGENOUS OPIOIDS AND OPIATE ANTAGONISTS IN AUTISM: BRIEF REVIEW OF EMPIRICAL FINDINGS AND IMPLICATIONS FOR CLINICIANS
Salvato in:
GILLBERG, C., ENDOGENOUS OPIOIDS AND OPIATE ANTAGONISTS IN AUTISM: BRIEF REVIEW OF EMPIRICAL FINDINGS AND IMPLICATIONS FOR CLINICIANS. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, Vol. 37, no. 3 (1995), p. 239-245.
Ref.
47722
Localizzazione:
SIIS R.727
Palabras clave:
Autismo, Bioquímica, Discapacidad, Discapacidad del lenguaje, Discapacidad intelectual, Trastornos del espectro autista
Autismo, Bioquímica, Discapacidad, Discapacidad del lenguaje, Discapacidad intelectual, Trastornos del espectro autista
Documenti analoghi: ENDOGENOUS OPIOIDS AND OPIATE ANTAGONISTS IN AUTISM: BRIEF REVIEW OF EMPIRICAL FINDINGS AND IMPLICATIONS FOR CLINICIANS
- Are opioid antagonists effective in attenuating the core symptoms of autism spectrum conditions in children: a systematic review
- EFFECTS OF THE OPIATE ANTAGONIST, NALTREXONE, ON BINGING ANTECEDENTS AND PLASMA BETA-ENDORPHIN CONCENTRATIONS
- Are opioid antagonists effective in reducing self-injury in adults with intellectual disability? A systematic review
- CATECHOLAMINERGIC METABOLISM AND AUTISM
- PLASMA AMINO ACID LEVELS IN CHILDREN WITH AUTISM AND THEIR FAMILIES
- PROOPIOMELANOCORTIN (POMC) DISREGULATION AND RESPONSE TO OPIATE BLOCKERS